Related Experiment Video
Updated: May 30, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Modulation of rifampicin toxicity by 6 MFA, an interferon inducer obtained from fungus Aspergillus ochraceus
1Department of Pharmacology and Toxicology, Research Centre, Hindustan Antibiotics Limited, Pimpri, Pune-411 018, India.
Abstract:
The effect of 6 MFA (Sixth mycelial fraction of acetone), an interferon inducer obtained from fungus Aspergillus ochraceus, on rifampicin toxicity was studied in rats. Chronic oral administration of rifampicin (1 g/kg per day) for 30 days produced thrombocytopenia, hemolytic anaemia, transient leukopenia and increased nucleated cells in bone marrow and decreased weights of thymus and spleen significantly in male rats. Furthermore, chronic administration of rifampicin induced significant increase in cytochrome P-450 contents, lipid peroxidation (LPO) and superoxide dismutase (SOD) activity in liver and bone marrow. Simultaneous administration of 6 MFA (100 mg/kg; i.p.) on alternate days for a period of 30 days prevented most of the adverse effects of rifampicin, mentioned earlier and also restored the hepatic architecture histologically. The LPO, cytochrome P 450 content, lymphocyte and bone marrow cell counts returned to normal level whereas SOD activity was further increased. The 6 MFA treatment enhanced the SRBC antibody litre in rifampicin-treated rats. Thus, beneficial effects of 6 MFA in the amelioration of mediated rifampicin toxicity observed in the present study may be through induction of interferons and their associated effects.
Insights
The Sixth Mycelial Fraction of Acetone (6 MFA) protected rats from rifampicin toxicity, preventing adverse effects like anemia and thrombocytopenia. This interferon inducer may offer a protective strategy against drug-induced side effects.
Area of Science:
- Pharmacology
- Immunology
- Mycology
Background:
- Rifampicin, an antibiotic, can cause significant toxicity.
- The Sixth Mycelial Fraction of Acetone (6 MFA) is an interferon inducer derived from Aspergillus ochraceus.
Purpose of the Study:
- To investigate the protective effects of 6 MFA against rifampicin-induced toxicity in rats.
- To explore the potential mechanisms underlying 6 MFA's beneficial effects.
Main Methods:
- Rats were administered rifampicin orally for 30 days.
- Simultaneous administration of 6 MFA (intraperitoneal) was given on alternate days.
- Hematological parameters, bone marrow, spleen, thymus weights, liver/bone marrow biochemical markers, and hepatic histology were assessed.
Main Results:
- Rifampicin caused thrombocytopenia, hemolytic anemia, leukopenia, altered bone marrow, and reduced organ weights.
- Rifampicin increased liver/bone marrow cytochrome P-450, lipid peroxidation (LPO), and superoxide dismutase (SOD) activity.
- 6 MFA treatment ameliorated most rifampicin-induced toxicities, restored hepatic architecture, normalized LPO and cytochrome P-450, and enhanced antibody production.
Conclusions:
- 6 MFA demonstrates significant protective effects against rifampicin-induced toxicity in rats.
- The beneficial effects of 6 MFA may be mediated through interferon induction and related immune responses.
- 6 MFA shows potential as an adjunct therapy to mitigate antibiotic-associated adverse events.
Related Concept Videos
Antifungal Agents
Inhibitors of Viral Protein Synthesis
Cryptococcal Meningitis
Rocky Mountain Spotted Fever

